1 Min Read
Jan 23 (Reuters) - Qiagen Nv:
* QIAGEN NV SAYS RECEIVED CLEARANCE FOR ITS IPSOGEN JAK2 RGQ PCR KIT FROM U.S. FDA FOR ADDITIONAL USE IN DIAGNOSIS OF ALL MYELOPROLIFERATIVE NEOPLASMS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.